Skip to main content
FinSpry Logo
FinSpry
AZN logo
AZN
(NYSE)
AstraZeneca PLC
$203.49-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AstraZeneca (AZN) Stock Price & Financial Analysis

AstraZeneca Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$199.23 - $204.34
52-Week High$212.71
52-Week Low$61.24
Open$199.78
Volume2.05M
Average Volume (3M)2.05M
Market Cap317.85B
Shares Outstanding1.56B
P/E Ratio (TTM)30.66
Forward P/E21.19
Price to Sales (P/S)5.34
Price to Book (P/B)6.44
EV/EBITDA16.92
Revenue (TTM)58.74B
Net Income (TTM)10.22B
Free Cash Flow (TTM)8.67B
EPS (TTM)$6.54
Profit Margin17.41%
Operating Margin23.40%
Return on Equity (ROE)21.01%
Debt to Equity0.57
50-Day MA$193.68
200-Day MA$131.11
52-Week Change176.49%
Annual Dividend$7.43
Dividend Yield3.70%
Payout Ratio113.65%
Last Dividend Ex-DateMar 23, 2027

Frequently Asked Questions About AstraZeneca

What is the current stock price for AZN?

As of the latest trading session, AZN stock trades at $203.49. The 52-week range is $61.24–$212.71, with a day range of $199.23–$204.34.

What is the P/E ratio for AZN?

AstraZeneca's trailing P/E ratio is 30.7, meaning investors pay $30.7 for every $1 of annual earnings. The forward P/E is 21.2, reflecting analyst expectations for future earnings. AstraZeneca operates in the Healthcare sector.

Does AZN pay dividends?

Yes, AstraZeneca pays a 3.70% annual dividend yield ($7.43 per share). The payout ratio is 113.7%. The last ex-dividend date was 2027-03-23.

What do analysts recommend for AZN?

Based on 18 analysts, the consensus for AZN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AZN?

AstraZeneca's market capitalization is $317.85B, classifying it as a mega-cap company. AstraZeneca operates in the Healthcare sector within the Drug Manufacturers - General industry.